Tag Archives: grant

TSB Annoucnes Grant for R&D

TSB Annoucnes Grant for R&D

Full Text Here

A new Technology Strategy Board scheme is offering funding to small and medium-sized enterprises (SMEs) to engage in R&D projects in the strategically important areas of science, engineering and technology, from which successful new products, processes and services could emerge.

Open from 4 April 2011, the Grant for Research and Development (Grant for R&D) scheme will support R&D projects which offer potentially significant rewards and could stimulate UK economic growth. In contrast to the Collaborative R&D programme, Grant for R&D funding is available to single companies.

Three types of grant are available:

  • Proof of market
  • Proof of concept
  • Development of prototype

Any UK SME working in any sector may apply; applications are accepted on a rolling basis for assessment by independent experts.

Grant for R&D replaces the scheme previously offered by regional development agencies. The new scheme will work alongside existing programmes in Scotland, Wales and Northern Ireland.

For Assistance with Preparing Business Plans for Fund Raising Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

Fill Out the Short Form Below…


  1. (required)


  2. (valid email required)

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

BUPA Foundation Strategy – Fund

BUPA Foundation Strategy – Fund

Full Text Here

The Bupa Foundation is an independent medical research charity

AIMS

The charitable objects (intentions) expressed above are interpreted in the aims to fund:

  1. Implementation of translational and action orientated research-based solutions, which: :
    • Drive tangible action to prevent or alleviate chronic disease or the adverse elements of ageing; and to promote wellbeing and/or
    • Lead to the sustained uptake of healthy lifestyles and/or
    • Measurably improve public health to a significant degree
  2. AND/OR

  3. Research which leads to the development of such solutions.

OBJECTIVES

The Foundation’s objectives are:
To offer grants to implement research-based solutions, in any of the following areas, which reflect global challenges in public health:

  1. Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace or educational establishments;
  2. Utilising or developing shared-decision making tools for better patient decisions for use amongst disadvantaged or diverse groups;
  3. Promoting and encouraging healthy ageing through physical activity and other behaviour-based and social solutions for the older age group (65+ years);
  4. Using new technologies to organise and interpret health outcomes data cheaply and effectively – for better design of community health activities and to improve patient decision making.

All projects should develop, apply or test research-based approaches in community settings – with clear intended impacts on public health.

The Bupa Foundation supports high quality medical research through its four programmes:

Programme 1: Research grants (all four objectives above)

In 2011 the first round under the new funding strategy will be held in June 2011. The closing date for this round is 31 March 2011. This may change in future years.

All projects funded under this heading should develop, apply or test research-based approaches in community settings – with clear intended impacts on public health.

The areas for funding as detailed above are not intended to be exclusive of each other.

Research grant applications are open only to clinicians, researchers and health care professionals who are UK residents. Applicants are encouraged to include on their application partnerships with other universities, healthcare organisations, research institutes, charities and community groups

The Foundation will normally consider applications for funding to a maximum of £100,000 per annum for up to three years term. Successful applications are more likely if added value (such as potential for co-funding) is clearly demonstrated.

If funding is required for a longer period a separate application must be made in the third year. Continuing support cannot be guaranteed; any application for further funding will be considered in open competition with other applications submitted on that occasion.

Programme 2: Annual Multi-country Grant

A total grant of up to £600,000 will be awarded to fund one multi-country* initiative of 1 to 3 years duration, under the first funding theme on sustained behaviour changes

“Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace or educational establishments”"

*This should be defined as a project carried out in at least two of the following countries: United Kingdom, Spain, Australia, New Zealand, the United States or India

It will be advertised on the Bupa Foundation web site and appropriate online journals.

In 2011 it will be judged in September, with a closing date of 20 June 2011.

This time table may change in future years.

Programme 3: Philip Poole-Wilson Seed Corn Fund

A fund of £200,000 per annum to award grants of up to £20,000 each, to fund research into any of the four Research Grant themes.

Each application must be made either by a researcher beginning their research career or if a pilot project by an experienced researcher, must include such a researcher on the team and contribute meaningfully to his/her development and training. High priority will be given to applications from young and/or new researchers who have not previously been funded.

Philip Poole-Wilson Seed Corn fund grant applications are open only to clinicians, researchers and health care professionals who are UK residents Applicants are encouraged to include on their application partnerships with other universities, healthcare organisations, research institutes, charities and community groups

This grant round will be held in November each year, with a closing date of 31 July.

Programme 4: Annual Prizes

£60,000 will be allocated for completed research and/or development that has been conducted over the past 3 years into each of the four Research themes; -

  1. Healthy Lives Prize
  2. Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace

  3. Patients as Partners Prize
  4. Utilising or developing shared-decision making tools for better patient decisions for use amongst disadvantaged or diverse groups;

  5. Vitality for Life Prize
  6. Promoting and encouraging healthy ageing through physical activity and other behaviour-based and social solutions for the older age groups (65+ years)

  7. Technology for Healthy Outcomes Prize
  8. Using new technologies to organise and interpret health outcomes data cheaply and effectively for better design of community health activities and improved patient decision making.

Foundation Prizes will focus on recognition of excellent work by aspiring and promising new researchers in the early phases of their career.

Foundation Prizes are advertised in January/February each year, with a closing date in early July. Full details of Awards entry criteria and the application process can be found at: http://www.bupafoundation.co.uk/asp/awards/eligibility.asp.

The Chairman and Board of Governors of the Bupa Foundation reserve the right to amend and/or add to Programme details as they consider appropriate, at any future date.

For Assistance with Grant Funding and Business Planning Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

Fill Out the Short Form Below…


  1. (required)


  2. (valid email required)

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

FDA Announces Grant Funding for Safety and Effectivenss of Orphan Products Rsearch Project Grant (R01)

FDA Announces Grant Funding for Safety and Effectiveness of Orphan Products Research Project Grant (R01)

Full Text Here

The Food and Drug Administration (FDA) is announcing the availability of grant funds for the support of FDA’s Office of Orphan Products Development (OPD) grant program. The goal of FDA’s OPD grant  program is to support the clinical development of products for use in rare diseases or conditions where no current therapy exists or where the proposed product will be superior to the existing therapy. FDA  provides grants for clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products. Applicants must include in the  application’s Background and Significance section documentation to support the estimated prevalence of the orphan disease or condition (or in the case of a vaccine or diagnostic, information to support the  estimates of how many people will be administered the diagnostic or vaccine annually) and an explanation of how the proposed study will either help support product approval or provide essential data needed
for product development.

For an Orphan Regulatory Expert EU or USA Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

First name

Phone #1

E-mail address

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

METRC Announce Short Term Project Funding

METRC Announce Short Term Project Funding £3000 going to £7000.

Short Term Project Funding is designed to support small research projects to explore the feasibility of innovative new products and processes. In the first stage, funds of up to £3,000 are available to support collaborative projects between METRC’s academic members and industry partners. The funding can be used flexibly at the METRC academic  institutions on a range of activities such as project consumables, paying for researchers or some limited consultancy work. For the most successful projects, funding can be extended into a second stage worth up to an additional £7,000 providing there is a matching contribution from an industrial partner.

he call will open on 16th October 2009 and funding will be available on a first-come first-served basis. We will be accepting applications for stage 2 funding from 1st January 2010 and there is funding available to support up to 10 stage 2 projects. We expect that a second tranche of Short Term Project Funding will be made available during 2010.

The Contacts Are:

Richard France – r.m.france@sheffield.ac.uk, 0114 222 9563
Simon Butler – simon.butler@sheffield.ac.uk, 0114 222 9450
Sam Whitehouse – S.P.Whitehouse@sheffield.ac.uk, 0114 222 9493

If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

ida 100programme 515x64 LowRes METRC Announce Short Term Project Funding

Turn your Business Into an Investor Magnet

How to Write a Business Plan – Free E-Course

Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free

Grow your Expertise for Free

As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

First name

E-mail address

This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
ida consultants freestrategyconsultation 515x64 METRC Announce Short Term Project Funding